Down -12.75% in 4 Weeks, Here's Why You Should You Buy the Dip in LivaNova (LIVN)Zacks Investment Research • 02/28/23
LivaNova Initiates Limited Commercial Release in Europe of the Essenz Perfusion System for Cardiopulmonary Bypass ProceduresBusiness Wire • 02/08/23
LivaNova Announces Receipt of Close-Out of Warning Letter from U.S. Food and Drug AdministrationBusiness Wire • 12/13/22
LivaNova to Present Scientific Data at American Epilepsy Society 2022 Annual MeetingBusiness Wire • 11/30/22
LivaNova Receives 510(k) Clearance for ECMO from FDA for LifeSPARC, the Next-generation Advanced Circulatory Support SystemBusiness Wire • 11/17/22
LivaNova to Present at the Stifel, Wolfe and Piper Sandler Healthcare ConferencesBusiness Wire • 11/08/22
LivaNova (LIVN) Expected to Beat Earnings Estimates: Should You Buy?Zacks Investment Research • 10/26/22
LivaNova PLC (LIVN) CEO Damien McDonald on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/07/22